Product Information
CELONTIN 300 MG CAPSULE is a brand product labeled by Pfizer Inc., priced at $4.4011 per EA under NDC 00071052524. Its NADAC has been published 384 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Pfizer Inc.NDC
00071052524
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHSUXIMIDEApproval Type
New Drug (NDA)
FDA Application
NDA010596On Market Since
2/8/1957
Pharmacological Classes
Price Statistics
The NADAC for CELONTIN 300 MG CAPSULE has been published 384 times since Nov 28, 2013, and over the history we have for it it has risen 124.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4011 per EA |
|---|---|
| All-time high | $4.4011 (Jun 24, 2026) |
| All-time low | $1.9592 (Nov 28, 2013) |
| 52-week high | $4.4011 |
| 52-week low | $4.3993 |
| Median price | $3.7529 |
| Average price | $3.4300 |
| Largest weekly change | +9.4% (Jan 4, 2017) |
| Weeks tracked | 384 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the methsuximide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CELONTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CELONTIN 300 MG CAPSULE, manufactured by Pfizer Inc., is $4.4011 per EA (NDC 00071052524), effective Jun 24, 2026.
How has the price of CELONTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CELONTIN 300 MG CAPSULE has risen 124.6%. It has been tracked across 384 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CELONTIN 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CELONTIN 300 MG CAPSULE has ranged from a low of $1.9592 (Nov 28, 2013) to a high of $4.4011 (Jun 24, 2026), with a median of $3.7529 per EA.
Are there cheaper alternatives to CELONTIN 300 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CELONTIN 300 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures CELONTIN 300 MG CAPSULE?
CELONTIN 300 MG CAPSULE (NDC 00071052524) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification